Socialiya - Entertainment. Knowledge. Community.
GLP-1 Receptor Agonist Use Linked to Lower Incidence of Obesity-Associated Cancers

For adults with obesity but without diabetes, GLP-1 RA use is associated with a significantly lower...

HEALTH NEWS June 17, 2026

GLP-1 Receptor Agonist Use Linked to Lower Incidence of Obesity-Associated Cancers

For adults with obesity but without diabetes, GLP-1 RA use is associated with a significantly lower short-term incidence of OACs.

3 views 0 likes 0 comments
Share:
For adults with obesity but without diabetes, GLP-1 RA use is associated with a significantly lower short-term incidence of OACs.

Author: Endocrinology Advisor

Read Original Article

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya